Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Exercise | $375K | SEC | |
| ExerciseD | $375K | SEC | |
| Buy | $112.6K | SEC | |
| Buy | $49.4K | SEC | |
| Buy | $61.8K | SEC | |
| Buy | $756K | SEC | |
| Buy | $1.3M | SEC | |
| Buy | $553.2K | SEC | |
| Buy | $119.7K | SEC | |
| Buy | $229.7K | SEC | |
| Buy | $707.3K | SEC | |
| Buy | $718.9K | SEC | |
| Buy | $72.3K | SEC | |
| Buy | $29K | SEC | |
| Buy | $111.6K | SEC | |
| Buy | $77.4K | SEC | |
| Buy | $134.2K | SEC |